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In vivo evaluation of snake fruit Kombucha as hyperglycemia therapeutic 
agent
Abstract
This research was a part of development of functional beverage through fermentation of snake 
fruit juice with Kombucha consortium. The aim of this research was to study on in vivo evaluation 
of snake fruit Kombucha as hyperglycemia therapeutic agent. The snake fruit (Salak Suwaru 
cultivar) juice was fermented for 14 days with the Kombucha consortium. Streptozotocin 
induced diabetic rats were used in the in vivo evaluation. The snake fruit Kombucha was 
orally administerred at different level for 28 days. The results revealed the treatment showed a 
significant fasting plasma glucose reduction in a range of 31-59%, consistent with improving of 
blood serum superoxide dismutase activity and malondialdehyde level. Immunohistochemical 
staining of pancreatic tissue proved a regeneration of the pancreatic beta cells in the groups of 
snake fruit Kombucha treatment compared to control group. Snake fruit Kombucha was proven 
as a hyperglycemia therapeutic agent in diabetic rats model. 
Introduction
Kombucha is a refreshing health-promoting 
beverage produced through fermentation by a 
symbiotic consortium of yeast species and acetic 
acid bacteria. In the Kombucha production, sugared 
tea infussion has been used as the fermentation 
substrate in traditional cultures. Researchers reported 
that several substrates other than tea had successfully 
applied in Kombucha production (Jayabalan et al., 
2014; Gamboa-Gomez et al., 2016). In our previous 
study, we found that sugared snake fruit juices are 
good substrates for the fermentation with Kombucha 
consortium with desirable overall properties of 
the fermented beverage (Zubaidah et al., 2018). 
Bioactive compounds including phenolic content, 
flavonoid, tannin and organic acids, along with the in 
vitro antioxidant and antibacteria activities have been 
detected in the snake fruit Kombucha. Therefore, the 
snake fruit Kombucha has a potential for development 
of functional beverages.
Many researchers reported antidiabetic 
bioactivity of kombucha tea (Greenwalt et al., 2000; 
Dufresne and Farnworth, 2000; Ernst, 2003; Aloulou 
et al., 2012; Srihari et al., 2013). Gamboa-Gomez 
et al. (2017) found that polyphenols contribute to 
the hypoglycemic effect of oak leaves Kombucha. 
Organic acids also contributed to the bioactivity 
(Fushimi et al., 2005). It indicate that the snake fruit 
Kombucha has potential as antidiabetic bioactivity.  
The aim of this research was to evaluate snake 
fruit Kombucha as a hyperglycemia therapeutic agent 
in diabetic animal models.
Materials and Methods 
Materials
Snake fruit (Salak Suwaru cultivar) of commercial 
maturity were obtained from plantations in Malang, 
East Java, Indonesia. Commercial Kombucha starter 
was purchased from a local distributor, while cane 
sugar was bought from a local supermarket.
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Preparation of snake fruit juice and Kombucha  
Preparation of the snake fruit juice and Kombucha 
were conducted as described in our previous research 
(Zubaidah et al., 2018). The sugared juice was 
inoculated with the Kombucha starter (1:10 w/w) and 
incubated for 14 days at room temperature. 
Experimental design
Twenty five healthy 3 months old male Wistar 
rats were divided randomly into 5 groups with 5 
replication. Group 1 (P0): normal rats; Group 2: 
diabetes mellitus/DM (P1); Group 3: DM with snake 
fruit Kombucha/KS at dose of 5 mL/kg BW/day (P2); 
Group 4: DM with KS at dose of 10 mL/kg BW/day 
(P3); and Group 5: DM with KS at dose of 15 mL/
kg BW/day (P4). DM rats induced by STZ (Nacalai 
Tesque, Japan) intraperitoneally at a dose of 47.5 mg/
kg body weight (BW). The rats were given access 
to standard diet and water ad libitum during 28 days 
experiment. The Group 3-5 were administered with 
snake fruit Kombucha orally once a day. FPG levels 
measurements were conducted on day 0 and day 28. 
At the end of the experiment, rats were sacrificed 
by cervical dislocation. Blood was used for the 
analysis of superoxide dismutase (SOD) activity and 
malondialdehyde (MDA) levels, while pancreas was 
used for immunohistochemical (IHC) staining.
SOD activity assay
SOD activity assay was referred to Bannisterb 
and Calabrese (1987). Serum was obtained by 
centrifugation of blood of rats at 3,500 rpm for 10 
mins. 200 µL of serum was put in the test tube, added 
with 200 µL of 100 mM EDTA, 100 µL of NBT, 100 
µL of xanthine, 100 µL of xanthine oxidase, then 
homogenized. The mixture was centrifuged at 3,000 
rpm for 5 min. Supernatant was taken and added with 
distilled water to a 3 ml volume, then absorbance was 
measured at 580 nm. SOD activity was calculated  by 
using standard curve.
Analysis of MDA  
MDA analysis was referred to Rael et al. (2004). 
200 µL of serum was put in the test tube, added with 
500 µL of TCA 40% and homogenized. 200 µL of 
1 N HCl, 500 µL of distilled water, 100 µL of 1% 
TBA were added, and then put in a 100°C heater for 
25 min. The mixture was cooled for 15 min and then 
centrifuged at 3,000 rpm for 10 min. Supernatant was 
removed and transferred into another tube. Distilled 
water was added to 3 ml, and absorbance was read at 
532 nm. MDA level was calculated by using standard 
curve.
Immunohistochemical staining
After sacrified, pancreas organ of rats was 
taken and fixed in buffered formalin10% for 24 h. 
Furthermore, slides were made by standard methods 
using paraffin. IHC staining was referred to Beesley 
(1995). Visualization was used diamino benzidine 
(DAB) for 3 min, while counterstaint used mayers 
haematoxilin for 3 min. Insulin was visualized as 
brown color. Quantification was referred to Suarsana 
et al. (2010) by calculating the average of beta cells. 
Statistical analysis
The data were analyzed by analysis of variance 
(ANOVA) and if any significant effect then further 
analyzed by LSD test at p < 0.05.
Results 
Effect of snake fruit Kombucha on FPG levels
The changes in FPG levels before and after 
treatment are shown in Figure 1, significant reduction 
of FPG in a range of 31-59% occured in the diabetic 
rats with snake fruit Kombucha treatment. This 
indicated the hyperglycemia therapeutic effect as a 
result of KS therapy. 
SOD activity and MDA levels
Hyperglycemia can trigger enhancement of 
the production of free radicals that can exacerbate 
complications in DM patients (Bhattacharya et 
al., 2013; Sayyid and Fleshner, 2016). KS proved 
to increase the SOD activity and lower MDA 
levels significantly than DM group (Table 1). This 
demonstrates the ability of KS in reducing oxidative 
stress due to the condition of hyperglycemia in a 
diabetic rats models. KS capability in reducing 
oxidative stress in this study are consistent with other 
study on tea kombucha (Bhattacharya et al., 2013).
IHC staining and pancreatic beta cells regeneration
IHC staining analysis results are shown in 
Figure 2 and Figure 3. There was an improvement of 
langerhans islands structure and function of insulin 
secretion in the three-groups KS treatment (P2-P4) 
compared to DM group (P1) (Figure 2). The size and 
shape of the langerhans island of DM group were 
smaller and irregular than normal group (P0) and 
three-group KS treatment. In addition, the DM group 
showed a very low immunoreactive response (brown 
color) against the anti-insulin which indicated low 
levels of insulin production.
In the three KS treatment groups, the number 
and arrangement of endocrine cells look more 
homogeneous, and the intensity of the brown 
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color was increased compared to the DM group. 
This indicated the regeneration of beta cells in the 
three KS treatment groups. Those results indicated 
a hyperglycemia therapeutic effect of KS in the 
improvement of langerhans island structure and 
regenerations of pancreatic beta cells.
Discussion
The in vivo study demonstrated the KS ability 
as a hyperglycemia therapeutic agent. A decrease in 
blood glucose level in this study can be expected due 
to the mechanism of increasing production of insulin, 
decreasing uptake of glucose from the digestive 
system, and increasing cellular glucose uptake. The 
antioxidant activity in KS is thought to provide a 
protective effect and repairs the pancreatic beta cells 
so that it can improve insulin secretion. This is proved 
by the result of the IHC analysis (Figure 2 and Figure 
3). Phenolic compounds are proven to increase insulin 
secretion from pancreatic beta cells (Johnson and de 
Mejia, 2016). Ultimately, improvement of insulin 
secretion will be able to lower blood glucose levels 
in hiperglicemia patients (Babu et al., 2013). The 
therapeutic effect is thought to be the role of phenolic 
compounds and organic acids contained in KS. The 
fermentation process is able to significantly increase 
the content of phenolic compounds and organic acids 
in KS that  increased antioxidant activity (Zubaidah 
et al., 2018).
Hyperglycemia also can be treated by reducing 
the amount of glucose absorbed from the digestive 
system. Foodstuffs containing phenolic compounds 
Figure 1. Changes in levels of FPG. Values are expressed 
as mean ± SD. The same lowercase indicated no significant 
differences between the data on day 0, while the same 
uppercase showed no significant differences between the 
data on day 28 (p <0.05).DM: Diabetes Mellitus, KS: 
Salacca var. Suwaru Kombucha, BW: Body Weight
Figure 2. IHC staining at 400x magnification microscope. 
P0: Normal, P1: DM, P2: DM + KS 5 ml/kg BW/day, 
P3: DM + KS 10 ml/kg BW/day, P4: DM + KS 15 ml/
kg BW/day, PL: Langerhans Island, EKS: Exocrine glands 
(acini), Yellow arrow: pancreatic beta cells which have 
immunoreactive to anti-insulin, Green arrow: endocrine 
cells which do not show immunoreactive to anti-insulin, 
Red arrow: empty space by necrosis, DM: Diabetes 
Mellitus, KS: Salacca var. Suwaru Kombucha, BW: Body 
Weight
Tabel 1. SOD activity and MDA levels 
Values are expressed as mean ± SD. The same letter show no 
significant differences between the data in the same column (p 
<0.05). DM: Diabetes Mellitus, KS: Salacca Suwaru Kombucha, 
BW: Body Weight
Figure 3. Average number of pancreatic beta cells. Values 
are expressed as mean ± SD number of beta cells of five 
langerhans islands. The same letter indicated no significant 
difference between data (p <0.05).DM: Diabetes Mellitus, 
KS: Salacca var Suwaru Kombucha, BW: Body Weight
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and organic acids are reported to decrease the 
absorption of glucose from the digestive system 
(Ostman et al., 2012; Aloulou et al., 2012; Kallel et 
al., 2012; Srihari et al., 2013). Tea kombucha can 
provide inhibitory effects on the activity of alpha-
amylase therefore suppresses the increase in blood 
glucose levels (Aloulou et al., 2012; Kallel et al., 
2012). Moreover, KS used in this study also contains 
organic acids and phenolic compounds (Zubaidah 
et al., 2018). In addition, the dominant organic acid 
contained in KS is acetic acid. Acetic acid is reported 
to suppress the action of the disaccharidase and can 
slow gastric emptying time that have implications 
for the inhibition of glucose levels in blood (Ogawa 
et al., 2000; Hlebowicz et al., 2007). Acetic acid 
can increase blood glucose uptake by the liver and 
muscles to be converted into glicogen (Fushimi et al., 
2005). 
In addition to lowering blood glucose levels, 
KS therapy can also prevent the negative effects 
of hyperglycemia conditions. Hyperglycemia can 
trigger enhancement of the production of free 
radicals that can exacerbate complications in DM 
patients (Bhattacharya et al., 2013; Sayyid et al., 
2016). Exposure to free radicals can potentially cause 
increasing damage to biological macromolecules, 
especially lipids. KS has a high antioxidant activity 
(Zubaidah et al., 2018) and proved to increase the 
SOD activity and lower MDA levels significantly 
than DM group (Table 1). Antioxidants in KS plays a 
role to improve the balance of oxidation status of the 
body, thereby reducing the workload of enzymatic 
antioxidants such as SOD, and reducing the 
formation of MDA. This demonstrates the ability of 
KS in reducing oxidative stress due to the condition 
of hyperglycemia in a diabetic rats models. KS 
capability in reducing oxidative stress in this study 
are consistent with other study on tea kombucha 
(Bhattacharya et al., 2013).
Conclusions
The developed beverage snake fruit Kombucha 
at doses of 5-15 ml/kg body weight/day showed 
an ability as a hyperglycemia therapeutic agent in 
diabetic animal models. Further research on clinical 
evaluation of the snake fruit Kombucha will be 
conducted.
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